Search

Your search keyword '"Frigeni, B"' showing total 204 results

Search Constraints

Start Over You searched for: Author "Frigeni, B" Remove constraint Author: "Frigeni, B"
204 results on '"Frigeni, B"'

Search Results

1. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)

2. Correction to: COVID‐19‐associated Guillain‐Barré syndrome in the early pandemic experience in Lombardia (Italy) (Neurological Sciences, (2023), 44, 2, (437-446), 10.1007/s10072-022-06429-6)

4. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

5. Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

6. ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016

7. Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

10. Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity

11. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

14. Quantitative EEG interpretation by EEG-naïve neurointensivists before and after expert training

18. Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study

19. Patologie della giunzione neuromuscolare

20. From observation to monitoring: implementation of quantitative electroencephalography (QEEG) in neurointensive care

21. Quantitative EEG in NICU. An Easily Interpretable Tool for the Intensivist?

22. From observation to monitoring: implementation of quantitative electroencephalography (QEEG) in neurointensive care

23. Patologie della giunzione neuromuscolare

24. Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus

25. Comparative effectiveness of dimethyl fumarate, teriflunomide, interferon-beta and glatiramer acetate on newly diagnosed patients: a propensity score-matched analysis from a multicenter Italian group

26. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

28. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

29. Comorbidities affect treatment choice and persistence in RRMS: a real-life multicenter study

30. To switch therapies in RRMS: why and when? A real-life multicentre study

31. Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy

32. Neurophysiological examination of dorsal sural nerve

33. Accidents in Patients with Epilepsy: Types, Circumstances, and Complications: A European Cohort Study

34. Morbidity in Patients with Epilepsy: Type and Complications: A European Cohort Study

35. Accidents in patients with epilepsy: types, circumstances, and complications: a European cohort study

36. The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale

37. Targeted immunotherapy in multiple sclerosis

38. Assessment of diabetic neuropathy using a multimodal approach: Results of a correlation study - The DEMAND study

41. The use of skin innervation density to assess course and severity of toxic neuropathies in animal models

42. TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy

43. Neuroprotective effect of erythropoietin in experimental cisplatin neuropathy: intraepidermal nerve fibre density and nerve conduction velocity correlation

45. Provider perceptions of clinical neuropathy examination usefulness

46. Clinical activity after fingolimod cessation: disease reactivation or rebound?

48. Efficacy and safety of glatiramer acetate in multiple sclerosis patients with allergic respiratory diseases

Catalog

Books, media, physical & digital resources